OEM News, People

NanoVibronix Has a Leadership Transition

Brian Murphy has retired as CEO; ENvue Medical CEO Doron Besser becomes the chief executive of NanoVibronix.

Brian Murphy (left) and Doron Besser (right). Photos: LinkedIn.

NanoVibronix revealed that Brian Murphy has retired as its CEO, effective immediately. The board appointed Doron Besser, CEO of the company’s subsidiary ENvue Medical, as its new CEO—also effective immediately.

Murphy will stay on the company’s board as a director, continuing his service to support governance continuity at the board level.

“Brian has been an integral part of NanoVibronix’s success, driving product innovation and spearheading initiatives to expand distribution and commercialize our unique therapeutic solutions,” said Christopher Fashek, NanoVibronix’s board chairman. “His dedication and leadership have helped to lay a solid foundation for the Company’s future. On behalf of the Board, I want to sincerely thank Brian for his service and enduring commitment to the Company.”

NanoVibronix acquired ENvue, an enteral feeding solutions company, in February 2025. NanoVibronix believes the transaction will bolster the combined company’s market position in enteral feeding tech and therapeutic medical devices. ENvue’s proprietary tech aligns with its commitment to patient safety and advanced medical solutions.

“I am honored to step into the role of CEO at such a pivotal time in the Company’s journey,” said newly appointed CEO Besser. “With the recent strategic combination of NanoVibronix and ENvue, I believe we are well-positioned to capitalize on new market opportunities, enhance our product portfolio and drive long-term stockholder value. I look forward to working with the Board and our talented team to continue the Company’s legacy of innovation and success.”

“It has been a tremendous privilege to lead NanoVibronix and collaborate with such a talented and dedicated team,” added outgoing CEO Murphy. “I am immensely proud of what we have accomplished together. With Doron at the helm, I am confident in the Company’s continued progress and future achievements. I am committed to supporting Doron and the Board as we transition into this exciting next chapter.”

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters